Sinclair Andrew's Form 4 filing
Adicet Bio, Inc. (ACET) · filed Dec 10, 2021
- Accession no.
- 0000905718-21-001587
- Filed
- Dec 10, 2021
- Trade date
- Dec 8, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $7.00M. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0000905718-21-001591 (Dec 13, 2021). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sinclair AndrewCIK 0001762451 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2021 | Common Stock | PPurchaseAcquired | +500,000 | $14.00 | +$7,000,000 | 2,140,721 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.